Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MTCP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C14orf39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC84214 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CLCN6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC284939 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAT8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP4R3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAP1L4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSMAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEL1L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CWC25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCSAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on